Results 301 to 310 of about 100,175 (352)
Some of the next articles are maybe not open access.

Ultrasound evaluation of PCO, PCOS and OHSS

Reproductive BioMedicine Online, 2004
Polycystic ovary syndrome (PCOS) and the concomitant androgen excess may be particularly distressing and disruptive for women. Thus, PCOS requires a prompt diagnosis and adequate treatment. However, the criteria used for diagnosis and definition of PCOS are as heterogeneous as the pathology itself.
BATTAGLIA, CESARE   +4 more
openaire   +4 more sources

PCOS

Nursing Standard, 2014
Essential facts Polycystic ovary syndrome (PCOS) is a common disorder that affects millions of women in the UK. It can affect a woman's menstrual cycle, fertility and aspects of her appearance. The three main features of the condition are cysts that develop in the ovaries, ovaries that do not regularly release eggs, and having high levels of androgens,
openaire   +2 more sources

Transgenerational PCOS transmission

Nature Medicine, 2019
There is a transgenerational increase in the susceptibility of female offspring to developing PCOS that occurs via the female germline and is linked to fetal exposure to excess androgen.
H M, Picton, A H, Balen
openaire   +2 more sources

PCOS.

BMJ clinical evidence, 2016
Polycystic ovary syndrome (PCOS) is diagnosed in up to 10% of women attending gynaecology clinics, but the prevalence in the population as a whole is unclear. PCOS has been associated with hirsutism, infertility, acne, weight gain, type 2 diabetes, cardiovascular disease (CVD), and endometrial hyperplasia.We conducted a systematic review and aimed to ...
openaire   +2 more sources

Dyslipidemia in PCOS

Steroids, 2012
Life-long apolipoprotein lipid metabolic dysfunction in women with PCOS exaggerates the risk for cardiovascular disease (CVD) with aging. The dysfunction has involved insulin resistance (IR), which occurs in most women with PCOS. Women with PCOS have androgen excess, IR, variable amounts of estrogen exposure, and many environmental factors, all of ...
openaire   +2 more sources

Pregnancy Complications in PCOS

Best Practice & Research Clinical Endocrinology & Metabolism, 2006
Complications of pregnancy associated with maternal PCOS include increased prevalence of early pregnancy loss (EPL), gestational diabetes (GDM), pregnancy-induced hypertensive disorders (PET/PIH), and the birth of small-for-gestational-age (SGA) babies.
openaire   +2 more sources

Lifestyle Modifications in PCOS

Clinical Obstetrics & Gynecology, 2020
Lifestyle modification is widely considered to be the cornerstone of polycystic ovary syndrome (PCOS) treatment. However, 45% of women with PCOS have reported that they have never been provided information about lifestyle management. This highlights a significant gap in knowledge and is reflective of the lack of evidence-based guidance for lifestyle ...
Jasmine M, Aly, Alan H, Decherney
openaire   +2 more sources

Clinical management of PCOS

Acta Obstetricia et Gynecologica Scandinavica, 2001
The polycystic ovary syndrome (PCOS) is a heterogeneous condition with genetic predisposition. It is characterized by a myriad of symptoms including oligomenorrhea or amenorrhea, anovulation or infertility, hirsutism or acne. Insulin resistance appears to be an important factor in PCOS though the lack of an etiology has led to symptom oriented therapy ...
W C, Tan, C, Yap, A S, Tan
openaire   +2 more sources

DHEA, DHEAS and PCOS

The Journal of Steroid Biochemistry and Molecular Biology, 2015
Approximately 20-30% of PCOS women demonstrate excess adrenal precursor androgen (APA) production, primarily using DHEAS as a marker of APA in general and more specifically DHEA, synthesis. The role of APA excess in determining or causing PCOS is unclear, although observations in patients with inherited APA excess (e.g., patients with 21-hydroxylase ...
Mark O, Goodarzi   +2 more
openaire   +2 more sources

Polycystic ovary syndrome (PCOS)

Annales d'Endocrinologie, 2010
1. The Rotterdam classification should be used to define PCOS in the event of: menstrual cycle anomalies; amenorrhoea, oligomenorrhoea or long cycles, clinical and/or biochemical hyperandrogenism and ultrasound appearance of polycystic ovaries. 2. The presence of two of these three criteria is sufficient once all other diagnoses have been ruled out. 3.
D, Dewailly   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy